Sulfamerazine EP Standard from Germany
Sulfamerazine, a short-acting sulfonamide antibiotic explicitly listed in HTS 2935.90.4200, meets European Pharmacopoeia standards for purity. Used in combination therapies for urinary tract infections, this bulk API represents a classic Chapter 29 sulfonamide classification. The product qualifies due to its specific chemical definition and anti-infective drug application.
Duty Rate — Germany → United States
25%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.3910%Except for products described in headings 9903.05.85–9903.05.92 and 9903.05.97, articles the product of a member state of the European Union, with an ad valorem (or ad valorem equivalent) rate of duty under column 1 less than 10 percent, as provided for in U.S. note 52 to this subchapter
Import Tips
• Provide EP certificate of analysis and demonstrate US pharmacopeial equivalence for faster FDA clearance
• Declare exact isomeric purity as mixtures of isomers follow specific Chapter 29 note 2(b) classification rules
• Avoid misclassification by specifying human pharmaceutical use vs research chemical applications